Patents Assigned to Althera Life Sciences LLC
  • Oral Tablet Formulation Consisting of Immediate Release Rosuvastatin and Extended Release Metformin
    Publication number: 20200222401
    Abstract: The present invention is directed to solid dosage product and formulation containing a fixed combination of rosuvastatin and metformin such that rosuvastatin is delivered immediately to the patient and metformin is delivered in a controlled fashion over a longer course of time, also described as extended release, as well as to methods of making such solid dosage forms and method of treating patients with fixed combination solid dosage forms of immediate release rosuvastatin and extended release metformin.
    Type: Application
    Filed: February 20, 2020
    Publication date: July 16, 2020
    Applicant: Althera Life Sciences, LLC
    Inventor: Marie Charmaine Dias
  • Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases
    Patent number: 10376470
    Abstract: Solid dosage formulations containing a combination of rosuvastatin and ezetimibe, as well as methods of making such solid dosage forms and method of treating patients with fixed combination solid dosage forms of rosuvastatin and ezetimibe are provided here.
    Type: Grant
    Filed: August 27, 2017
    Date of Patent: August 13, 2019
    Assignee: Althera Life Sciences, LLC
    Inventors: Marie Charmaine Dias, Chandir Ramani
  • ORAL TABLET FORMULATION CONSISTING OF IMMEDIATE RELEASE ROSUVASTATIN AND EXTENDED RELEASE METFORMIN
    Publication number: 20140212488
    Abstract: A solid dosage product and formulation containing a fixed combination of rosuvastatin and metformin is provided here. In the formulation rosuvastatin is delivered immediately to the patient and metformin is delivered in a slower controlled fashion over a longer course of time. A method to make the formulations as well as a method to treat patients with fixed combination solid dosage form of immediate release rosuvastatin and extended release metformin are provided here.
    Type: Application
    Filed: April 11, 2014
    Publication date: July 31, 2014
    Applicant: Althera Life Sciences LLC
    Inventor: Marie Charmaine Dias